Literature DB >> 15663133

The role of clinical follow up in early stage cervical cancer in South Wales.

K C K Lim1, R E J Howells, A S Evans.   

Abstract

OBJECTIVE: To assess the effectiveness of clinical follow up after primary surgery for early stage cervical cancer.
DESIGN: Retrospective analysis of clinical follow up after radical hysterectomy and node dissection for early stage cervical cancer.
SETTING: Gynaecological Oncology Cancer Centre. SAMPLE: Two hundred and ninety-one patients who underwent surgery for cervical cancer.
METHODS: Follow up data were collected retrospectively from hand-searched patients notes, as well as a computerised database (Information System for Clinical Organisation [ISCO]). The data were analysed using the SPSS for windows (SPSS, Chicago, Illinois) statistics package, using chi2, Kaplan-Meier life tables and Cox Linear regression analysis. MAIN OUTCOME MEASURES: To determine whether routine follow up was useful for detecting early recurrent disease.
RESULTS: Two hundred and ninety-one patients treated by radical hysterectomy and node dissections were followed up. The cumulative five-year survival for all cases in our series was 80% and 53/291 patients (18.2%) were found to have recurrent disease. The median period from surgery to recurrence was 17.6 months (3.0-60.0). Seven patients with recurrence were detected at a routine follow up examination, and two out of seven of the patients were asymptomatic. Detection of the recurrence on routine follow up was not an independent prognostic factor for survival when compared with age, stage and whether the patient received post-operative adjuvant therapy.
CONCLUSIONS: Routine follow up in patients following radical hysterectomy and node dissection for early stage cervical cancer is not a sensitive way of detecting recurrent disease, as a high proportion of patients were symptomatic at the time of detection. As there are other reasons for follow up, we propose alternative methods of structuring the programme.

Entities:  

Mesh:

Year:  2004        PMID: 15663133     DOI: 10.1111/j.1471-0528.2004.00280.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

Review 1.  Management of cervical cancer: summary of SIGN guidelines.

Authors:  R M James; M E Cruickshank; N Siddiqui
Journal:  BMJ       Date:  2008-01-05

2.  Risk factors and clinical aspects of recurrent invasive cervical carcinoma.

Authors:  Fatemeh Ghaemmaghami; Sorayya Saleh-Gargari; Behrokh Sahebdel; Nadereh Behtash; Farhad Samiei
Journal:  J Obstet Gynaecol India       Date:  2012-09-04

3.  Follow-up for women after treatment for cervical cancer.

Authors:  L Elit; A W Fyles; T K Oliver; M C Devries-Aboud; M Fung-Kee-Fung
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

4.  Trial of Optimal Personalised Care After Treatment for Gynaecological cancer (TOPCAT-G): a study protocol for a randomised feasibility trial.

Authors:  Kirstie Pye; Nicola Totton; Nicholas Stuart; Rhiannon Whitaker; Val Morrison; Rhiannon Tudor Edwards; Seow Tien Yeo; Laura J Timmis; Caryl Butterworth; Liz Hall; Tekendra Rai; Zoe Hoare; Richard D Neal; Clare Wilkinson; Simon Leeson
Journal:  Pilot Feasibility Stud       Date:  2016-11-23

5.  Pattern of Failure with Locally Advanced Cervical Cancer– A Retrospective Audit and Analysis of Contributory Factors

Authors:  Anis Bandyopadhyay; Upasana Mukherjee; Sandip Ghosh; Saurav Ghosh; Shyamal Kumar Sarkar
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.